Organization
Wuhan Recogen Biotechnology
1 clinical trial
Clinical trial
A Randomized, Observer-Blinded, Placebo-Controlled Phase I Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of One Dose Booster by A Lyophilized COVID-19 mRNA Vaccine in Adults Aged 18 to 60 YearsStatus: Withdrawn, Estimated PCD: 2022-09-01